Clinical Trial Update: A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2, Phase 3]

View source ↗

Summary

A long-term study in amyotrophic lateral sclerosis (ALS) is reported as completed for a Phase 2/Phase 3 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2, Phase 3 | Status: COMPLETED